4,189 Shares in Astera Labs, Inc. (NASDAQ:ALAB) Bought by Landscape Capital Management L.L.C.

Landscape Capital Management L.L.C. acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 4,189 shares of the company’s stock, valued at approximately $555,000.

Other hedge funds have also recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Astera Labs by 5.7% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,284 shares of the company’s stock worth $277,000 after purchasing an additional 284 shares during the last quarter. Quarry LP purchased a new position in shares of Astera Labs in the 3rd quarter worth approximately $109,000. Stifel Financial Corp grew its holdings in shares of Astera Labs by 141.2% in the third quarter. Stifel Financial Corp now owns 98,461 shares of the company’s stock valued at $5,158,000 after acquiring an additional 57,638 shares in the last quarter. State Street Corp increased its position in shares of Astera Labs by 173.1% during the third quarter. State Street Corp now owns 698,467 shares of the company’s stock valued at $36,593,000 after acquiring an additional 442,698 shares during the last quarter. Finally, Wellington Management Group LLP bought a new stake in Astera Labs during the third quarter worth $16,031,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Stock Down 4.9 %

ALAB stock opened at $52.94 on Monday. The stock has a 50-day simple moving average of $78.49 and a two-hundred day simple moving average of $91.05. Astera Labs, Inc. has a twelve month low of $36.22 and a twelve month high of $147.39. The firm has a market capitalization of $8.58 billion and a PE ratio of -30.60.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%. On average, equities research analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Michael E. Hurlston sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $92.08, for a total value of $230,200.00. Following the sale, the director now directly owns 91,794 shares of the company’s stock, valued at $8,452,391.52. This trade represents a 2.65 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, General Counsel Philip Mazzara sold 50,000 shares of the business’s stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $87.46, for a total transaction of $4,373,000.00. Following the completion of the transaction, the general counsel now directly owns 191,209 shares of the company’s stock, valued at approximately $16,723,139.14. This represents a 20.73 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 633,990 shares of company stock worth $54,235,012.

Analyst Ratings Changes

Several brokerages have recently issued reports on ALAB. Raymond James initiated coverage on Astera Labs in a research report on Friday, March 14th. They set an “outperform” rating and a $82.00 target price for the company. Northland Capmk raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 28th. Barclays increased their target price on shares of Astera Labs from $87.00 to $135.00 and gave the company an “overweight” rating in a research report on Friday, January 17th. Needham & Company LLC reaffirmed a “buy” rating and issued a $140.00 price target on shares of Astera Labs in a report on Tuesday, February 11th. Finally, Stifel Nicolaus increased their price objective on Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a report on Monday, January 6th. One investment analyst has rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Astera Labs currently has a consensus rating of “Buy” and an average price target of $112.77.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.